Feder Julie B
SEC insider (Form 3/4/5 filer). CIK 0001710237. Chief Financial Officer at Obsidian Therapeutics, Inc. (OBX) and 1 other issuer. 4 reported Form 4/5 transactions since Sep 2024; latest on Oct 18, 2024. Located in BOSTON, MA.
Companies Feder Julie B has filed insider reports for
- Obsidian Therapeutics, Inc. (OBX): Officer, Chief Financial Officer
- Aura Biosciences, Inc. (AURA): Officer, Chief Financial Officer
Feder Julie B
CIK: 0001710237
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)1 (25.0%)
Position reduction
Option Exercises (M)3 (75.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Oct 18, 2024AURA
Aura Biosciences, Inc.
ExerciseDirect17.5K shares at avg. $2.74$48K - Oct 18, 2024AURA
Aura Biosciences, Inc.
ExerciseDirect2.6K shares at avg. $4.25$11K - Oct 18, 2024AURA
Aura Biosciences, Inc.
ExerciseDirect5K shares at avg. $5.48$27K - Oct 18, 2024AURA
Aura Biosciences, Inc.
SaleDirect25.1K shares at avg. $12.03$302K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 18, 2024 |  AURA Aura Biosciences, Inc. | Exercise | 17,500 | $2.74 | $47,950 | Direct |
| Oct 18, 2024 | AURA Aura Biosciences, Inc. | Exercise | 2,631 | $4.25 | $11,182 | Direct |
| Oct 18, 2024 | AURA Aura Biosciences, Inc. | Exercise | 5,000 | $5.48 | $27,400 | Direct |
| Oct 18, 2024 | AURA Aura Biosciences, Inc. | Sale | 25,131 | $12.03 | $302,361 | Direct |
1-4 of 4 transactions